Abstract
It is a challenge to establish and use model systems for the study of complex neuropsychiatric diseases such as schizophrenia (SZ) and autism spectrum disorder (ASD). The development of induced pluripotent stem cell (iPSC) technologies now offers a promising approach which faithfully represents the varying genetic background of individual patients. Phenotypic analysis of iPSC-derived neurons reveals differences at the level of transcriptomes and calcium signalling allowing for a specific discrimination between SZ and ASD phenotypes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
